Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.120
+0.010 (0.47%)
At close: May 20, 2026, 4:00 PM EDT
2.120
0.00 (0.00%)
After-hours: May 20, 2026, 4:10 PM EDT
Alector Market Cap
Alector has a market cap or net worth of $235.37 million as of May 20, 2026. Its market cap has increased by 102.92% in one year.
Market Cap
235.37M
Enterprise Value
75.06M
1-Year Change
102.92%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $235.37M, a decrease of -80.87%. That is a compound annual growth rate of -20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 234.26M | 37.58% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAB Biotherapeutics | 249.48M |
| Anavex Life Sciences | 247.43M |
| Protara Therapeutics | 243.93M |
| Editas Medicine | 240.85M |
| Orchestra BioMed Holdings | 239.52M |
| Coherus Oncology | 228.29M |
| Adagene | 224.65M |
| Codexis | 223.61M |